Skip to content

Fulgent Genetics, Inc. FLGT Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

SPS Commerce logo
SPS CommerceSPSC
$4.87M+54.2%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$4.39M+4.3%
Q2 Holdings logo
Q2 HoldingsQTWO
$45.49M+26.0%
AMN Healthcare logo
AMN HealthcareAMN
-$4.41M-312%
Rackspace Technology, Inc. logo
Rackspace Technology, Inc.RXT
$35.6M+483%
Calix logo
CalixCALX
$675K-80.6%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income?
Fulgent Genetics, Inc. (FLGT) reported increase (decrease) in contract liabilities and current deferred income of -$627K in Q1 2026.
How has Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Fulgent Genetics, Inc.'s increase (decrease) in contract liabilities and current deferred income decreased by 207.7% year-over-year, from $582K to -$627K.